Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-10 | Fred E. Cohen, M.D., D.Phil. was appointed to the Board in July 2013. Dr. Cohen serves as a Partner at TPG and Managing Director at TPG Biotech. The 2014 Director Compensation table shows Fred E. Cohen, M.D., D.Phil. received total compensation of $124,738. Effective on June 1, 2014, Dr. Cohen elected to receive his retainer in the form of shares of our common stock (in lieu of cash) equivalent in value to the fees earned. |
| 2016-04-11 | Fred E. Cohen, M.D., D.Phil. was appointed to the Board in July 2013. ... Dr. Cohen's extensive expertise in the pharmaceutical industry, private investment expertise and experience serving on boards of biotechnology companies contribute valuable insight and experience to the Board. |
| 2017-04-12 | Fred E. Cohen, M.D., D.Phil. was appointed to the Board in July 2013. ... He serves on the Compensation Committee. ... 2016 Director Compensation table shows Fred E. Cohen total compensation of $128,064. |
Data sourced from SEC filings. Last updated: 2026-02-03